Erratum regarding “Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD” (Am J Kidney Dis. 2016;68(6):892-900) (American Journal of Kidney Diseases (2016) 68(6) (892–900), (S0272638616303742), (10.1053/j.ajkd.2016.07.021));Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKD

American Journal of Kidney Diseases

Volumn 68, Issue 6, 2016, Pages 892-900

  Liu, Xun ^a   Foster, Meredith C ^b   Tighiouart, Hocine ^b   Anderson, Amanda H ^c   Beck, Gerald J ^d   Contreras, Gabriel ^e   Coresh, Josef ^f   Eckfeldt, John H ^g   Feldman, Harold I ^c   Greene, Tom ^h   Hamm, L Lee ⁱ   He, Jiang ^j,o   Horwitz, Edward ^k   Lewis, Julia ^l   Ricardo, Ana C ^m   Shou, Haochang ^c   Townsend, Raymond R ^c   Weir, Matthew R ⁿ   Inker, Lesley A ^b   Levey, Andrew S ^b   Appel, Lawrence J ^o   Go, Alan S ^o   Kusek, John W ^o   Lash, James P ^o   Ojo, Akinlolu ^o   Rahman, Mahboob ^o   more..

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF MINNESOTA   (United States)

^h UNIVERSITY OF UTAH   (United States)

ⁱ TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j TULANE UNIVERSITY   (United States)

^k Metrohealth ^*  (United States)

^l VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁿ UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^o NONE

more..

Author keywords

beta trace protein (BTP); beta 2 microglobulin (B2M); biomarker; creatinine; cystatin C; determinants of kidney function; estimation of kidney function; filtration marker; Glomerular filtration rate (GFR); kidney disease

Indexed keywords

BETA 2 MICROGLOBULIN; BETA TRACE PROTEIN; CREATININE; CYSTATIN C; PLASMA PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISOMERASE; LIPOCALIN; PROSTAGLANDIN R2 D-ISOMERASE;

ADULT; ARTICLE; BODY WEIGHT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; SMOKING; URINARY EXCRETION; BLOOD; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; KIDNEY FUNCTION TEST; METABOLISM; MOLECULAR WEIGHT;

BETA 2-MICROGLOBULIN; BIOMARKERS; BLOOD PROTEINS; COHORT STUDIES; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; KIDNEY FUNCTION TESTS; LIPOCALINS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; RENAL INSUFFICIENCY, CHRONIC;

EID: 84994765277     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2024.04.001     Document Type: Erratum

References (34)

1. 1 Miller G. Practices and recommendations for reporting estimated glomerular filtration rate (eGFR). http://www.cap.org/apps/docs/committees/chemistry/current_status_reporting_egfr2013.pdf, Accessed August 19, 2015.
2. 2 Stevens, L.A., Coresh, J., Greene, T., Levey, A.S., Assessing kidney function–measured and estimated glomerular filtration rate. N Engl J Med 354:23 (2006), 2473–2483.
3. 3 Levey, A.S., Inker, L.A., Coresh, J., GFR estimation: from physiology to public health. Am J Kidney Dis 63:5 (2014), 820–834.
4. 4 Stevens, L.A., Zhang, Y., Schmid, C.H., Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol 21:6 (2008), 797–807.
5. 5 Inker, L.A., Schmid, C.H., Tighiouart, H., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367:1 (2012), 20–29.
6. 2-microglobulin in CKD. Am J Kidney Dis 67:1 (2016), 40–48.
7. 7 Bhavsar, N.A., Appel, L.J., Kusek, J.W., et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis 58:6 (2011), 886–893.
8. 8 Tangri, N., Inker, L.A., Tighiouart, H., et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol 23:2 (2012), 351–359.
9. 9 Astor, B.C., Shafi, T., Hoogeveen, R.C., et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis 59:5 (2012), 653–662.
10. 10 Foster, M.C., Inker, L.A., Hsu, C.Y., et al. Filtration markers as predictors of end-stage renal disease and mortality in Southwestern American Indians. Am J Kidney Dis 66:1 (2015), 75–83.
11. 11 Foster, M.C., Coresh, J., Hsu, C.Y., et al. Serum beta-trace protein and beta-microglobulin as predictors of ESRD, mortality, and cardiovascular disease in adults with CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study [published online ahead of print March 3, 2016]. Am J Kidney Dis 68:1 (2016), 68–76.
12. 12 Foster, M.C., Inker, L.A., Levey, A.S., et al. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis 62:1 (2013), 42–51.
13. 13 Stevens, L.A., Schmid, C.H., Greene, T., et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:6 (2009), 652–660.
14. 14 Anderson, A.H., Yang, W., Hsu, C.Y., et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 60:2 (2012), 250–261.
15. 15 Greene, T., Bourgoignie, J.J., Habwe, V., et al. Baseline characteristics in the Modification of Diet in Renal Disease Study. J Am Soc Nephrol 4:5 (1993), 1221–1236.
16. 16 Gassman, J.J., Greene, T., Wright, J.T. Jr., et al. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). J Am Soc Nephrol 14:7 suppl 2 (2003), S154–S165.
17. 17 Feldman, H.I., Appel, L.J., Chertow, G.M., et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods. J Am Soc Nephrol 14:7 suppl 2 (2003), S148–S153.
18. 18 Levey, A.S., Greene, T., Schluchter, M.D., et al. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 4:5 (1993), 1159–1171.
19. 19 Li, L., Greene, T., Varying coefficients model with measurement error. Biometrics 64:2 (2008), 519–526.
20. 20 McMahon, G.M., Waikar, S.S., Biomarkers in nephrology: Core Curriculum 2013. Am J Kidney Dis 62:1 (2013), 165–178.
21. 21 Macdonald, J., Marcora, S., Jibani, M., et al. GFR estimation using cystatin C is not independent of body composition. Am J Kidney Dis 48:5 (2006), 712–719.
22. 22 Knight, E.L., Verhave, J.C., Spiegelman, D., et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:4 (2004), 1416–1421.
23. 23 Mathisen, U.D., Melsom, T., Ingebretsen, O.C., et al. Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 22:5 (2011), 927–937.
24. 24 Rule, A.D., Bailey, K.R., Lieske, J.C., Peyser, P.A., Turner, S.T., Estimating the glomerular filtration rate from serum creatinine is better than from cystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 83:6 (2013), 1169–1176.
25. 25 White, C.A., Ghazan-Shahi, S., Adams, M.A., Beta-trace protein: a marker of GFR and other biological pathways. Am J Kidney Dis 65:1 (2015), 131–146.
26. 26 Schardijn, G.H., Statius van Eps, L.W., Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int 32:5 (1987), 635–641.
27. 27 Ploegh, H.L., Orr, H.T., Strominger, J.L., Major histocompatibility antigens: the human (HLA-A, -B, -C) and murine (H-2K, H-2D) class I molecules. Cell 24:2 (1981), 287–299.
28. 28 White, C.A., Akbari, A., Doucette, S., et al. Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations. Kidney Int 76:7 (2009), 784–791.
29. 2-microglobulin, cystatin C, and creatinine in the US population. Clin J Am Soc Nephrol 8:4 (2013), 584–592.
30. 30 Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1 (2013), 1–150.
31. 31 Fan, L., Levey, A.S., Gudnason, V., et al. Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals. J Am Soc Nephrol 26:8 (2014), 1982–1989.
32. 32 Fan, L., Inker, L.A., Rossert, J., et al. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transplant 29:6 (2014), 1195–1203.
33. 33 Teo, B.W., Xu, H., Wang, D., et al. Estimating glomerular filtration rates by use of both cystatin C and standardized serum creatinine avoids ethnicity coefficients in Asian patients with chronic kidney disease. Clin Chem 58:2 (2012), 450–457.
34. 34 Eckfeldt, J.H., Karger, A.B., Miller, W.G., Rynders, G.P., Inker, L.A., Performance in measurement of serum cystatin C by laboratories participating in the College of American Pathologists 2014 CYS survey. Arch Pathol Lab Med 139:7 (2015), 888–893.